Multimodálna liečba tymického karcinoidu: kazuistika
[Multimodal treatment of thymic carcinoid: a case report]
Jazyk čeština Země Česko Médium print
Typ dokumentu kazuistiky, časopisecké články
PubMed
31163970
PII: 112428
- Klíčová slova
- peptide radionuclide receptor therapy, somatostatine analogues, thymic carcinoid,
- MeSH
- karcinoid * terapie MeSH
- kombinovaná terapie MeSH
- lidé MeSH
- nádory brzlíku * terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
Thymic carcinoid account for cca 0.4 % of all carcinoid tumors in the body [1]. As compared to other neuroendocrinne tumors, high rates of reccurences after surgery, more aggressive behaviour and relatively high rates of paraneoplastic syndromes are characteristic for thymic carcinoid. The mainstay of treatment is radical surgery [2-4]. Therapy of locally advanced and metastatic stages is influenced by other neuroendocrinne tumors´guidelines. We present a case report of patient with locally advanced, atypical thymic carcinoid, treated with different modalities, including newer procedures like peptide radionuclide receptor therapy (PRRT).